Page 23 - Sohini Das

Booster shot: Mounjaro may emerge as a sweet pill for Eli Lilly in India

Analysts say the diabetes and obesity drug can be a Rs 500 crore opportunity for the firm

Italian super-luxury carmaker Lamborghini's India drive: Catch them young

India ranks 6th in Asia-Pac for the Italian super luxury carmaker

Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India. Prices here

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what you need to know

Premium tyres market to treble in 3-5 years: CEAT MD & CEO Arnab Banerjee

Currently, commercial vehicle tyres and passenger vehicle tyres are split 50:50 in Ceat's sales. PCR sales account for around 20 per cent of passenger vehicle tyres

India sales may rev up soon to be among top 5 markets for Mercedes-Maybach

Mercedes-Benz India had its best year in its 30-year history in 2024, selling 19,565 vehicles-a 12.4 per cent year-on-year growth

Diarrhoea and viral infections spur sales of probiotics, shows data

Antidiarrheals and anti-flatulents have also grown in strong double digits - 36 per cent and 29 per cent, respectively

IIT-B startup HaystackAnalytics plans to take genome testing to EU, US

Srivastava says that in the next five years they need to invest another $40-50 million or so to build the business, and there are plans to take the infexn test to the US and Europe as well

PV sales to end FY25 flat with 3.82 mn units sold in wholesale till Feb

Auto industry braces for sluggish growth in FY26 amid affordability concerns

Generics surge as patent expiry restores mkt pulse, boosting drug volumes

An analysis by Pharmarack, a market research firm, showed that 226 vildagliptin (anti-diabetic) brands are now available in the market after Novartis' patent expired in December 2019

Key diabetes drug price crashes by up to 90% as generics enter market

Mankind, Alkem, Glenmark launch generic versions of empagliflozin

JLR-Tata plant in Tamil Nadu will reach peak capacity in 5-7 years: TaMo

The company further added that the specific models and production timelines will be aligned with Tata Passenger Electric Mobility (TPEM) and JLR broader strategy and market requirements.

Manipal, IHH in race to acquire Pune's Sahyadri Hospitals for Rs 6,000 cr

India is among the top markets globally for IHH and contributes around 16-17 per cent to its global revenues

Zydus Lifesciences to buy 86% stake in Amplitude Surgical for Rs 2,430 cr

Zydus will file a mandatory cash tender offer for the remaining shares of Amplitude at the same purchase price of €6.25 per share

Aveo Pharma suspects misuse of painkiller Tafrodol in importing countries

The company also clarified that the "stop production" order of Feb 24 was due to compliance issues under the Schedule M of the Drugs and Cosmetics Rules, 1945, and not due to the combination product

Hyundai's Rs 31,526 crore related-party transactions under scrutiny

Proxy advisory firms divided over supporting the transactions

Carmakers dangle deep discounts to lure buyers back into showrooms

Benefits in March range from Rs 35,000-4 lakh price cuts on various models

Tesla entering India with much fanfare but latter a challenging mkt for EVs

The potential impact on domestic EV manufacturers, government policies, and the broader market also remain subjects of speculation

Eliminate import duty on drugs from US: Pharma exporters to Centre

The exporters' worry is understandable as the US is the largest export market for Indian pharma accounting for 31.35 percent of India's overall pharma exports worth $27.8 bn

Ultraviolette hits the gas, to come out with 10 new e 2-wheelers in 3 years

At present they can make 10,000 two-wheelers a year, easily scalable up to 30,000 units a year in three shifts

Metropolis strengthens UP presence with acquisition of Scientific Pathology

The move aims to strengthen Metropolis' position in the western Uttar Pradesh market where Scientific Pathology has a strong presence